TO THE EDITOR:
Many of the innovations recommended by Margolius and Bodenheimer (1) for after-hours primary care in the U.S. health care system are already present in England's National Health Service (NHS) (1) . All residents of England have access to free afterhours primary care services from the NHS, either provided by their own primary care physician or by their local primary care trust (that is, the organization responsible for funding primary care services). After-hours primary care in England is defined as care that occurs outside the hours of 8 a.m. to 6:30 p.m., Monday through Friday, in contrast to some other countries, in which primary care physicians may offer narrower access to routine services (2) .
When primary care physicians provide after-hours services themselves, it is usually through a cooperative system. In areas where primary care physicians do not provide after-hours care, it is usually provided by a commercial provider and is funded by the local primary care trust. In addition to these primary care-based services, residents of England also have access to a 24-hour telephone advice line (NHS Direct) that has been available nationwide since 2000 (3) . Other recent innovations in emergency and after-hours care introduced urgent care centers and minor injury units that are staffed by primary care physicians and nurses, and employment of primary care physicians in emergency departments to handle patients who present with problems that do not need to be managed by specialist emergency physicians.
Despite the wide availability of primary care services and a readily accessible 24-hour helpline, patient attendance at emergency departments, urgent care centers, and minor injury units in England continues to rise-a 35% increase from 15.3 million first attendances (2003) (2004) to 20.7 million (2010 -2011) (4). The explanations for this continued demand for emergency care in a health system with good primary care, during both routine hours and after hours, are complex but seem to be linked to sociocultural reasons, such as the desire of patients to be seen when it is convenient for them (5) . The lesson from England for the United States and other countries with more fragmented and less widely available after-hours primary care services is that a health system can strive hard to improve access to after-hours primary care, but this by itself may not be enough to curtail the demands placed on emergency departments.
IN RESPONSE:
We thank Dr. Miller and Dr. Majeed for their letters. We have no disagreements with their comments, which underline the challenges facing primary care. Emergency departments have a great access advantage over traditional primary care practices-patients can go in at 6 p.m. or 1 a.m. and be seen the same day. However, the benefits of continuity of care through improved preventive and chronic care, higher patient satisfaction, and lower costs (1), can only be achieved by empanelling patients to a primary care home and ensuring prompt access to that medical home. Shining examples exist of primary care practices in the United States that provide both prompt access and continuity (2) : We read with disappointment the first recommendation of recently published guidelines (1) on the diagnosis and management of stable chronic obstructive pulmonary disease (COPD). This recommendation states, "Spirometry should not be used to screen for airflow obstruction in individuals without respiratory symptoms" (1). In our opinion, this would be like recommending that fasting blood glucose not be measured in obese patients until angina develops. Even if spirometry does not in itself modify the underlying risk (smoking cessation) or warrant immediate treatment (use of bronchodilators), airflow limitation is a marker of premature death from all causes-in particular, heart attack and lung cancer (2, 3) .
We believe this recommendation reflects an unduly nihilistic attitude toward the wider use of spirometry, primarily owing to its poor implementation to date rather than poor clinical utility. By not screening high-risk individuals, such as chronic asymptomatic smokers, we are losing a teachable moment that demonstrates to smokers their inherent susceptibility and irreversible end-organ damage.
That smokers do not quit smoking in greater numbers in response to poor spirometry results is possibly because physicians do not sufficiently emphasize the substantial increased risk for heart attack and lung cancer conferred by reduced FEV 1 (2, 3) . Moreover, if we wait for symptoms before spirometry is offered, many smokers will have irreversibly lost as much as 50% of lung function (2) . Evidence shows that the greatest potential to optimize lung health (preservation of lung function and reduced lung cancer risk) comes from quitting smoking before significant airflow limitation is established.
Another lost opportunity would be in identifying smokers most at risk for lung cancer (3) at a time when computed tomography (CT)-based screening for lung cancer seems to show a significant survival benefit (4). For lung cancer screening to be widely and cost-effectively adopted, it is necessary to identify current and former smokers at greatest risk, over and above that conferred by age and exposure (3).
If we abandon spirometric screening of asymptomatic smokers, we will lose this opportunity, as we and others have shown reduced FEV 1 confers a 6-fold greater risk for lung cancer compared with smokers with normal lung function (5) . We believe that the utility of spirometry as a diagnostic test is far outweighed by its ability to establish end-organ lung damage, increased all-cause mortality, and targeted risk-mitigating interventions. In our view, to abandon spirometry in asymptomatic smokers will certainly promote (if not worsen) the continued underdiagnosis and underresourcing of COPD. 
There are agreed-upon criteria that define when to consider screening (1): There should be an accepted treatment available, and if treatment is started at an early stage, it must be beneficial and change clinical outcomes compared with waiting until patients develop signs or symptoms of disease. The current evidence indicates that identification and treatment of individuals with asymptomatic airflow obstruction does not improve clinical outcomes and that spirometry does not act as a motivator to help patients stop smoking (1-4) .
In addition, we found no evidence to support the use of routine periodic spirometry after initiation of therapy to monitor disease status or to guide therapy modification. On the contrary, spirometry in asymptomatic patients may be associated with such harms as "labeling," follow-up visits, repeated office spirometry, full pulmonary function tests with bronchodilator testing, lung imaging, and use of unnecessary and ineffective treatments (5) . With this evidence in mind, there is no net benefit to obtaining spirometry in asymptomatic individuals. 
NICE Guideline for Management of Chronic Heart Failure in Adults
TO THE EDITOR: The National Institute for Health and Clinical Excellence (NICE) guidelines presented by Mant and colleagues (1) for management of chronic heart failure in adults describe the problem as "a complex clinical syndrome." The diagnostic algorithm begins with a detailed history and a clinical examination.
However, the authors then say, "Clinical signs and symptoms are of limited use in the diagnosis of heart failure" (1). This must surely be a misprint.
The next node down in the algorithm is either "Specialist assessment and Doppler echocardiography" or "Measure serum natriuretic peptide." Are these the real tools to diagnose of heart failure? It seems to be another example of gizmo idolatry (2) .
Clinical evaluation is central to nearly all complex clinical syndromes; history is almost everything in diagnosing ischemic heart disease, stroke, dementia, and more. Downplaying history and physical examination is harmful to physicians and their patients in many ways. And it seems to belittle the diagnosis and management of heart failure by physicians around the world who lack access to these technologies and must rely solely on clinical skills.
TO THE EDITOR:
I accept the evidence-based suggestion in Mant and colleagues' article (1) that specialists and coordinated care in heart failure clinics can create better outcomes than "usual" care. But I cannot find the evidence base that supports the need for specialist assessment to diagnose chronic heart failure in patients with prior myocardial infarction.
Generalists are capable of reviewing echocardiogram reports (generated by appropriately trained echocardiographers) that tell them whether a patient has preserved ejection fraction, systolic dys-function, or other cardiac abnormality, which can help to further classify patients with heart failure. If these physicians are able to diagnose chronic heart failure in patients without myocardial infarction, they ought to be able to do so in patients with prior myocardial infarction.
I have no problem with referral to cardiologists or chronic heart failure management clinics at this point, but I do not see the evidence for referral to a "specialist assessment" to make the diagnosis in the first place.
David L. Simel, MD, MHS Duke University Durham, NC 27705
Potential Conflicts of Interest: None disclosed.
IN RESPONSE:
We are grateful to Dr. Finucane for his comments and agree with him regarding the central role of history and physical examination in the evaluation of heart failure (and other complex clinical syndromes). It is through history and examination that a clinician will suspect heart failure as a diagnosis and consider potential aggravating factors and alternative diagnoses (1) . However, the limitations of symptoms and signs alone need to be acknowledged.
A systematic review of the evidence found that individual symptoms and signs are of limited use in the diagnosis of heart failure (2). Furthermore, diagnoses of heart failure by generalists may be inaccurate: A review of 103 patients with a diagnostic label of heart failure in primary care in the United Kingdom confirmed this diagnosis in 35 patients (34%) after echocardiography and examination (3) .
Echocardiography is required in persons with suspected heart failure not only to help establish whether the syndrome is present but also to help identify the underlying cardiac abnormality, such as left ventricular systolic dysfunction or valve disease. This is vital, because subsequent management is underpinned by such knowledge (1). There is a strong evidence base that measurement of serum natriuretic peptides is useful to rule out heart failure and thus can reduce the use of echocardiography in people with normal heart function (1, 2). The central role of natriuretic peptides and echocardiography in the NICE guideline does not reflect "gizmo idolatry," rather a considered application of the principles of evidence-based medicine.
We are also grateful to Dr. Simel for his comments, but we believe that he may have misinterpreted the algorithm. The guidelines recommend that all patients with heart failure should have specialist assessment and echocardiography. People with a history of myocardial infarction who present with symptoms and signs suggestive of heart failure have a higher likelihood of a positive diagnosis than someone without such a history (2) . Cost-effectiveness analysis suggests that it is more cost-effective to refer such people immediately for echocardiography and specialist assessment without the prior use of natriuretic peptide testing as a "rule out" test (2). In the case of patients with symptoms and signs of heart failure but no history of myocardial infarction, the diagnostic algorithm recommends that the generalist refer them for echocardiography and specialist assessment if serum natriuretic peptide levels are increased.
Hip Fracture: A Complex Illness Among Complex Patients
TO THE EDITOR: Hung and Morrison's editorial (1) on management of hip fracture does not address the patient in whom hip fracture will not be surgically repaired. I have had only a couple such patients who made the decision not to have surgery and were more than a few days from death. Both were competent to make their own choices, and despite encouragement to reconsider, these elderly patients stood firm and chose to die in their beds.
In caring for these patients, I could not convince anesthesiologists to consider regional approaches that might mitigate the need to use substantial narcotic analgesia and that might make it easier to maintain hygiene and to keep skin intact. PIER (http://pier.acponline.org) does mention the need to provide "adequate" doses of narcotic analgesia in persons who will not have surgical repair, thus at least noticing the problem. However, regional anesthesia could be continuous (for example, epidural) and could allow for a much more comfortable course. We should test this approach and report on the results so that patients and their physicians who choose this course have the benefit of prior experience.
